IDEAYA Biosciences (IDYA) Competitors $21.92 -0.71 (-3.14%) Closing price 04:00 PM EasternExtended Trading$21.90 -0.02 (-0.07%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA vs. RVMD, BBIO, ELAN, VRNA, LEGN, TGTX, GRFS, LNTH, TLX, and NUVLShould you be buying IDEAYA Biosciences stock or one of its competitors? The main competitors of IDEAYA Biosciences include Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), Verona Pharma (VRNA), Legend Biotech (LEGN), TG Therapeutics (TGTX), Grifols (GRFS), Lantheus (LNTH), Telix Pharmaceuticals Limited American Depositary Shares (TLX), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. IDEAYA Biosciences vs. Its Competitors Revolution Medicines BridgeBio Pharma Elanco Animal Health Verona Pharma Legend Biotech TG Therapeutics Grifols Lantheus Telix Pharmaceuticals Limited American Depositary Shares Nuvalent Revolution Medicines (NASDAQ:RVMD) and IDEAYA Biosciences (NASDAQ:IDYA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations. Which has more volatility & risk, RVMD or IDYA? Revolution Medicines has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, IDEAYA Biosciences has a beta of 0.04, suggesting that its stock price is 96% less volatile than the S&P 500. Do institutionals & insiders have more ownership in RVMD or IDYA? 94.3% of Revolution Medicines shares are held by institutional investors. Comparatively, 98.3% of IDEAYA Biosciences shares are held by institutional investors. 8.2% of Revolution Medicines shares are held by company insiders. Comparatively, 2.5% of IDEAYA Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor RVMD or IDYA? In the previous week, IDEAYA Biosciences had 4 more articles in the media than Revolution Medicines. MarketBeat recorded 5 mentions for IDEAYA Biosciences and 1 mentions for Revolution Medicines. IDEAYA Biosciences' average media sentiment score of 1.08 beat Revolution Medicines' score of 0.94 indicating that IDEAYA Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Revolution Medicines Positive IDEAYA Biosciences Positive Does the MarketBeat Community favor RVMD or IDYA? IDEAYA Biosciences received 40 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 78.03% of users gave Revolution Medicines an outperform vote while only 71.86% of users gave IDEAYA Biosciences an outperform vote. CompanyUnderperformOutperformRevolution MedicinesOutperform Votes10378.03% Underperform Votes2921.97% IDEAYA BiosciencesOutperform Votes14371.86% Underperform Votes5628.14% Is RVMD or IDYA more profitable? IDEAYA Biosciences' return on equity of -26.74% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Revolution MedicinesN/A -33.67% -30.08% IDEAYA Biosciences N/A -26.74%-25.54% Do analysts prefer RVMD or IDYA? Revolution Medicines presently has a consensus target price of $67.08, indicating a potential upside of 64.46%. IDEAYA Biosciences has a consensus target price of $54.27, indicating a potential upside of 147.59%. Given IDEAYA Biosciences' higher possible upside, analysts clearly believe IDEAYA Biosciences is more favorable than Revolution Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00IDEAYA Biosciences 0 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.93 Which has preferable earnings & valuation, RVMD or IDYA? IDEAYA Biosciences has higher revenue and earnings than Revolution Medicines. Revolution Medicines is trading at a lower price-to-earnings ratio than IDEAYA Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevolution Medicines$742K10,239.72-$436.37M-$4.00-10.20IDEAYA Biosciences$7M274.26-$274.48M-$3.59-6.11 SummaryIDEAYA Biosciences beats Revolution Medicines on 12 of the 18 factors compared between the two stocks. Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDYA vs. The Competition Export to ExcelMetricIDEAYA BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.92B$6.85B$5.57B$8.61BDividend YieldN/A2.56%5.28%4.18%P/E Ratio-6.648.7827.1720.06Price / Sales274.26255.64409.72157.10Price / CashN/A65.8538.2534.64Price / Book1.816.557.064.70Net Income-$274.48M$143.93M$3.23B$247.88M7 Day Performance3.89%3.74%2.68%2.20%1 Month Performance26.19%13.94%12.02%9.44%1 Year Performance-41.67%4.62%31.24%14.72% IDEAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDYAIDEAYA Biosciences3.7969 of 5 stars$21.92-3.1%$54.27+147.6%-41.0%$1.92B$7M-6.6480Positive NewsAnalyst RevisionRVMDRevolution Medicines4.3054 of 5 stars$40.58-1.2%$67.08+65.3%+5.3%$7.56B$742K-11.30250BBIOBridgeBio Pharma4.6134 of 5 stars$39.03+1.1%$57.36+47.0%+44.1%$7.41B$127.42M-13.69400Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionELANElanco Animal Health1.385 of 5 stars$13.94+0.3%$15.17+8.8%-21.7%$6.92B$4.43B34.859,800Positive NewsVRNAVerona Pharma2.4785 of 5 stars$84.64+0.4%$82.13-3.0%+586.0%$6.86B$118.54M-44.0830Trending NewsAnalyst ForecastAnalyst RevisionLEGNLegend Biotech3.1066 of 5 stars$34.78-0.6%$76.20+119.1%-17.3%$6.39B$728.30M-36.611,070Trending NewsShort Interest ↑Analyst RevisionTGTXTG Therapeutics2.7751 of 5 stars$39.84-0.5%$40.80+2.4%+148.0%$6.32B$386.39M-398.36290Positive NewsAnalyst RevisionGRFSGrifols3.6363 of 5 stars$8.83+0.1%N/A+26.9%$6.07B$7.21B7.5526,300LNTHLantheus4.4114 of 5 stars$83.22+2.0%$132.67+59.4%+1.4%$5.76B$1.54B13.85700TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.91+0.8%$22.00+30.1%N/A$5.72B$783.21M0.00N/APositive NewsNUVLNuvalent2.1633 of 5 stars$76.08-2.5%$115.50+51.8%-0.7%$5.46BN/A-21.9340 Related Companies and Tools Related Companies Revolution Medicines Alternatives BridgeBio Pharma Alternatives Elanco Animal Health Alternatives Verona Pharma Alternatives Legend Biotech Alternatives TG Therapeutics Alternatives Grifols Alternatives Lantheus Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDYA) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDYA Stock Free IDYA Stock Alerts